Glenmark Makes Progress On Favipiravir Clinical Trials

FabiFlu Could Prevent Patients From Progressing To ARDS

Blue_Capsules
Phase III clinical trials of favipiravir demonstrates swifter improvement in mild-to-moderate Covid-19 patients • Source: Shutterstock

More from Archive

More from Generics Bulletin